In Other News

• Blood Test Markers Could Help Identify Older Adults at Risk of Disability

• FDA Clears Roche Blood Test for Alzheimer’s Amyloid Pathology Assessment

• Age-Related Genomic Differences Could Refine Treatment Decisions in Lung Cancer

• Molecular Pathway Reveals Driver of Triple-Negative Breast Cancer Spread

• FDA Clears Roche Blood Test for Alzheimer’s Amyloid Pathology Assessment

• New Collaboration Advances Precision Oncology Screening for Lung Cancer in Japan

• AI-Based Antibody Profiling Predicts Strength of COVID-19 Vaccine Response

• AI-Pathologist Framework Improves Accuracy and Reliability in Cancer Diagnosis

• New Review Highlights Intelligent Agents as Next Step for Digital Pathology

• Rapid Ferritin Test Enables Iron Deficiency Detection at the Point of Care

• Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

• AI-Powered Pathology Collaboration Supports Companion Diagnostic Development

• Simple Whole-Blood Screen Identifies Elevated Bile Acids Linked to Liver Disease

• Autonomous Robotic System Receives FDA Authorization for Blood Collection

• Routine Urine Protein Testing Identifies Undiagnosed Chronic Kidney Disease

• Autonomous Robotic System Receives FDA Authorization for Blood Collection

• Genetic Risk Score Identifies Type 1 Diabetes in MODY Testing

• Self-Collected HPV Testing Reaches Patients Missed by Routine Screening

• Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

• Longitudinal Heart Stress Assessment Improves Prediction of Cardiovascular Outcomes

• Blood Test Measuring Tumor Proliferation May Guide Treatment Sequencing in Metastatic Melanoma

• Comprehensive Genomic Testing Expands Treatment Options for Advanced Cancers

• 30-Minute 3D Histology Tool Supports Intraoperative Glioma Margin Assessment